Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)

Jason J. LeBlanc; May ElSherif; Lingyun Ye; D. MacKinnon-Cameron; Ardith Ambrose; Todd F. Hatchette; Amanda L.S. Lang; Hayley D. Gillis; I. Martin; Walter Demczuk; Melissa K. Andrew; Guy Boivin; William Bowie; K. Green; Jennie Johnstone; Mark Loeb; Anne E. McCarthy; Allison McGeer; Makeda Semret; Sylvie Trottier; L. Valiquette; Duncan Webster; Shelly A. McNeil

doi:10.1016/j.vaccine.2019.05.003

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)

Jason J. LeBlanc, May ElSherif, Lingyun Ye, D. MacKinnon-Cameron, Ardith Ambrose, Todd F. Hatchette, Amanda L.S. Lang, Hayley D. Gillis, I. Martin, Walter Demczuk, Melissa K. Andrew, Guy Boivin, William Bowie, K. Green, Jennie Johnstone, Mark Loeb, Anne E. McCarthy, Allison McGeer, Makeda Semret, Sylvie TrottierL. Valiquette, Duncan Webster, Shelly A. McNeil

科研成果: 期刊稿件 › 文章 › 同行评审

32 引用（Scopus）

源语言	英语
页（从-至）	5466-5473
页数	8
期刊	Vaccine
卷	37
期	36
DOI	https://doi.org/10.1016/j.vaccine.2019.05.003
出版状态	已出版 - 8月 23 2019

!!!ASJC Scopus Subject Areas

分子药学
一般免疫学和微生物学
一般兽医学
公共卫生、环境和职业健康
传染病学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1016/j.vaccine.2019.05.003

其它文件与链接

指纹

探究 'Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)' 的科研主题。它们共同构成独一无二的指纹。

引用此

LeBlanc, J. J., ElSherif, M., Ye, L., MacKinnon-Cameron, D., Ambrose, A., Hatchette, T. F., Lang, A. L. S., Gillis, H. D., Martin, I., Demczuk, W., Andrew, M. K., Boivin, G., Bowie, W., Green, K., Johnstone, J., Loeb, M., McCarthy, A. E., McGeer, A., Semret, M., ... McNeil, S. A. (2019). Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN). Vaccine, 37(36), 5466-5473. https://doi.org/10.1016/j.vaccine.2019.05.003

Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN). / LeBlanc, Jason J.; ElSherif, May ; Ye, Lingyun 等.
在: Vaccine, 卷 37, 号码 36, 23.08.2019, 页码 5466-5473.

科研成果: 期刊稿件 › 文章 › 同行评审

LeBlanc, JJ , ElSherif, M , Ye, L , MacKinnon-Cameron, D, Ambrose, A, Hatchette, TF, Lang, ALS, Gillis, HD, Martin, I, Demczuk, W, Andrew, MK, Boivin, G, Bowie, W, Green, K, Johnstone, J, Loeb, M, McCarthy, AE, McGeer, A, Semret, M, Trottier, S, Valiquette, L, Webster, D & McNeil, SA 2019, 'Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)', Vaccine, 卷 37, 号码 36, 页码 5466-5473. https://doi.org/10.1016/j.vaccine.2019.05.003

LeBlanc JJ , ElSherif M , Ye L , MacKinnon-Cameron D, Ambrose A, Hatchette TF 等. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN). Vaccine. 2019 8月 23;37(36):5466-5473. doi: 10.1016/j.vaccine.2019.05.003

LeBlanc, Jason J. ; ElSherif, May ; Ye, Lingyun 等. / Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia : A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN). 在: Vaccine. 2019 ; 卷 37, 号码 36. 页码 5466-5473.

@article{2432b130c2d441faac50d0ef03bffdc9,

title = "Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)",

author = "LeBlanc, {Jason J.} and May ElSherif and Lingyun Ye and D. MacKinnon-Cameron and Ardith Ambrose and Hatchette, {Todd F.} and Lang, {Amanda L.S.} and Gillis, {Hayley D.} and I. Martin and Walter Demczuk and Andrew, {Melissa K.} and Guy Boivin and William Bowie and K. Green and Jennie Johnstone and Mark Loeb and McCarthy, {Anne E.} and Allison McGeer and Makeda Semret and Sylvie Trottier and L. Valiquette and Duncan Webster and McNeil, {Shelly A.}",

note = "Funding Information: This work was supported by the Public Health Agency of Canada (PHAC), the Canadian Institutes of Health Research (CIHR), and by an investigator-initiated research grant to CIRN from Pfizer Canada. No study sponsors were involved in study design, specimen collection, analysis and interpretation of data, scientific writing, or decision to submit the paper for publication. The grant identification numbers associated with the funding were CIHR 23338, GSK1106, and PF1001. Funding Information: The authors would like to thank all CIRN SOS surveillance monitors and staff at the Canadian Center for Vaccinology (CCfV) who were instrumental in the recruitment, collection, and processing of CAP and IPD specimens. Also, the technical assistance of the laboratory staff at the Streptococcus and Sexual Transmitted Diseases unit of the National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC), was greatly appreciated. Publisher Copyright: {\textcopyright} 2019 The Authors",

year = "2019",

month = aug,

day = "23",

doi = "10.1016/j.vaccine.2019.05.003",

language = "English",

volume = "37",

pages = "5466--5473",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "36",

}

TY - JOUR

T1 - Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia

T2 - A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN)

AU - LeBlanc, Jason J.

AU - ElSherif, May

AU - Ye, Lingyun

AU - MacKinnon-Cameron, D.

AU - Ambrose, Ardith

AU - Hatchette, Todd F.

AU - Lang, Amanda L.S.

AU - Gillis, Hayley D.

AU - Martin, I.

AU - Demczuk, Walter

AU - Andrew, Melissa K.

AU - Boivin, Guy

AU - Bowie, William

AU - Green, K.

AU - Johnstone, Jennie

AU - Loeb, Mark

AU - McCarthy, Anne E.

AU - McGeer, Allison

AU - Semret, Makeda

AU - Trottier, Sylvie

AU - Valiquette, L.

AU - Webster, Duncan

AU - McNeil, Shelly A.

N1 - Funding Information: This work was supported by the Public Health Agency of Canada (PHAC), the Canadian Institutes of Health Research (CIHR), and by an investigator-initiated research grant to CIRN from Pfizer Canada. No study sponsors were involved in study design, specimen collection, analysis and interpretation of data, scientific writing, or decision to submit the paper for publication. The grant identification numbers associated with the funding were CIHR 23338, GSK1106, and PF1001. Funding Information: The authors would like to thank all CIRN SOS surveillance monitors and staff at the Canadian Center for Vaccinology (CCfV) who were instrumental in the recruitment, collection, and processing of CAP and IPD specimens. Also, the technical assistance of the laboratory staff at the Streptococcus and Sexual Transmitted Diseases unit of the National Microbiology Laboratory (NML), Public Health Agency of Canada (PHAC), was greatly appreciated. Publisher Copyright: © 2019 The Authors

PY - 2019/8/23

Y1 - 2019/8/23

UR - http://www.scopus.com/inward/record.url?scp=85069705417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069705417&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2019.05.003

DO - 10.1016/j.vaccine.2019.05.003

M3 - Article

C2 - 31345638

AN - SCOPUS:85069705417

SN - 0264-410X

VL - 37

SP - 5466

EP - 5473

JO - Vaccine

JF - Vaccine

IS - 36

ER -